发明申请
US20110152504A1 CD16A Binding Proteins and Use for the Treatment of Immune Disorders
审中-公开
CD16A结合蛋白和用于治疗免疫疾病的用途
- 专利标题： CD16A Binding Proteins and Use for the Treatment of Immune Disorders
- 专利标题（中）： CD16A结合蛋白和用于治疗免疫疾病的用途
-
申请号： US12904554申请日： 2010-10-14
-
公开(公告)号： US20110152504A1公开(公告)日： 2011-06-23
- 发明人: Leslie S. Johnson , Ling Huang , Hua Li , Nadine Tuaillon
- 申请人： Leslie S. Johnson , Ling Huang , Hua Li , Nadine Tuaillon
- 申请人地址： US MD Rockville
- 专利权人： MacroGenics, Inc.
- 当前专利权人： MacroGenics, Inc.
- 当前专利权人地址： US MD Rockville
- 主分类号： C07K16/28
- IPC分类号： C07K16/28
摘要：
CD 16A binding proteins useful for the reduction of a deleterious immune response asre described. In one aspect, humanized anti-cd16A antibodies, optionally lacking effector function, are used for the treatment of immune disorders such as idiopathic thrombocytopenic purpura and autoimme hemolytic anemia.
信息查询
